Climaco John M

Director at PERMA FIX ENVIRONMENTAL SERVICES INC · on record since Oct 15, 2013
Director at InfuSystem Holdings, Inc · on record since Apr 26, 2012
Director at STAR OPERATING COMPANIES, INC. · on record since Jun 5, 2012
Director at INTERPACE BIOSCIENCES, INC. · on record since Nov 4, 2013
Director at ALCO STORES INC · on record since Sep 11, 2014
Director at Essex Rental Corp. · on record since Jun 24, 2015
Director at BIRNER DENTAL MANAGEMENT SERVICES INC · on record since Jun 21, 2017
Director at Moleculin Biotech, Inc. · on record since Jul 26, 2017
Director at CNS Pharmaceuticals, Inc. · on record since Nov 8, 2019
Chief Executive Officer at CNS Pharmaceuticals, Inc. · on record since Nov 8, 2019

Insider trading activity of Climaco John M

Transactions on record: 61; since Apr 26, 2012

Open-market buys: 8; $120.3K

Open-market sells: 0

Companies traded: 8; last filing Nov 19, 2025

Figures computed from official regulatory filings — .

Companies where Climaco John M has traded

CNS Pharmaceuticals, Inc.15 tx · $81.5K · Nov 19, 2025
Moleculin Biotech, Inc.11 tx · Nov 14, 2025
STAR OPERATING COMPANIES, INC.20 tx · $55K · Aug 19, 2019
BIRNER DENTAL MANAGEMENT SERVICES INC3 tx · Jan 14, 2019
Essex Rental Corp.1 tx · Oct 5, 2015
PERMA FIX ENVIRONMENTAL SERVICES INC8 tx · $51.9K · Jul 1, 2015
2 tx · $105K · Jun 5, 2014
1 tx · Apr 26, 2012

Track record of Climaco John M

Statistical track record

Free account

Open-market buys: 8

Last buy: Feb 1, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Climaco John M

Co-insiders of Climaco John M

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
CNS Pharmaceuticals, Inc.Listing on record	Nov 19, 2025	AwardD (derivative)	9,761	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Moleculin Biotech, Inc.Listing on record	Nov 14, 2025	AwardD (derivative)	150,000	—	n/a (No price was disclosed in the filing)		SEC
Moleculin Biotech, Inc.Listing on record	Nov 6, 2024	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Apr 10, 2024	AwardD (derivative)	83,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Apr 10, 2024	AwardD (derivative)	83,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Feb 6, 2024	AwardD (derivative)	166,666	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Feb 6, 2024	AwardD (derivative)	166,666	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Feb 6, 2024	Buy	166,666	0.30 USD	$50K	conv 93ClusterUnusual size	SEC
CNS Pharmaceuticals, Inc.Listing on record	Aug 16, 2023	Buy	2,750	1.80 USD	$5K	conv 32	SEC
Moleculin Biotech, Inc.Listing on record	May 26, 2023	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	May 1, 2023	ExerciseD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	May 1, 2023	Exercise	1,250	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Apr 14, 2023	Buy	15,000	0.69 USD	$10.4K	conv 60First in 12mo	SEC
CNS Pharmaceuticals, Inc.Listing on record	Mar 31, 2023	AwardD (derivative)	16,467	—	n/a (No price was disclosed in the filing)		SEC
Moleculin Biotech, Inc.Listing on record	Jun 22, 2022	AwardD (derivative)	23,333	—	n/a (No price was disclosed in the filing)		SEC
Moleculin Biotech, Inc.Listing on record	Jun 22, 2022	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Apr 29, 2022	AwardD (derivative)	600,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Mar 8, 2022	Award	35,000	0.28 USD	$9.8K		SEC
CNS Pharmaceuticals, Inc.Listing on record	Nov 18, 2021	Award	5,000	1.28 USD	$6.4K		SEC
Moleculin Biotech, Inc.Listing on record	Jun 9, 2021	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Feb 9, 2021	AwardD (derivative)	310,000	—	n/a (No price was disclosed in the filing)		SEC
Moleculin Biotech, Inc.Listing on record	Jun 17, 2020	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
STAR OPERATING COMPANIES, INC.Listing on record	Aug 19, 2019	AwardD (derivative)	2,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
STAR OPERATING COMPANIES, INC.Listing on record	Aug 8, 2019	ExerciseD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
STAR OPERATING COMPANIES, INC.Listing on record	Aug 8, 2019	Exercise	1,250	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
CNS Pharmaceuticals, Inc.Listing on record	Nov 19, 2025	AwardD (derivative)	9,761	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Moleculin Biotech, Inc.Listing on record	Nov 14, 2025	AwardD (derivative)	150,000	—	n/a (No price was disclosed in the filing)		SEC
Moleculin Biotech, Inc.Listing on record	Nov 6, 2024	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Apr 10, 2024	AwardD (derivative)	83,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Apr 10, 2024	AwardD (derivative)	83,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Feb 6, 2024	AwardD (derivative)	166,666	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Feb 6, 2024	AwardD (derivative)	166,666	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Feb 6, 2024	Buy	166,666	0.30 USD	$50K	conv 93ClusterUnusual size	SEC
CNS Pharmaceuticals, Inc.Listing on record	Aug 16, 2023	Buy	2,750	1.80 USD	$5K	conv 32	SEC
Moleculin Biotech, Inc.Listing on record	May 26, 2023	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	May 1, 2023	ExerciseD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	May 1, 2023	Exercise	1,250	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Apr 14, 2023	Buy	15,000	0.69 USD	$10.4K	conv 60First in 12mo	SEC
CNS Pharmaceuticals, Inc.Listing on record	Mar 31, 2023	AwardD (derivative)	16,467	—	n/a (No price was disclosed in the filing)		SEC
Moleculin Biotech, Inc.Listing on record	Jun 22, 2022	AwardD (derivative)	23,333	—	n/a (No price was disclosed in the filing)		SEC
Moleculin Biotech, Inc.Listing on record	Jun 22, 2022	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Apr 29, 2022	AwardD (derivative)	600,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Mar 8, 2022	Award	35,000	0.28 USD	$9.8K		SEC
CNS Pharmaceuticals, Inc.Listing on record	Nov 18, 2021	Award	5,000	1.28 USD	$6.4K		SEC
Moleculin Biotech, Inc.Listing on record	Jun 9, 2021	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
CNS Pharmaceuticals, Inc.Listing on record	Feb 9, 2021	AwardD (derivative)	310,000	—	n/a (No price was disclosed in the filing)		SEC
Moleculin Biotech, Inc.Listing on record	Jun 17, 2020	AwardD (derivative)	15,000	—	n/a (No price was disclosed in the filing)		SEC
STAR OPERATING COMPANIES, INC.Listing on record	Aug 19, 2019	AwardD (derivative)	2,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
STAR OPERATING COMPANIES, INC.Listing on record	Aug 8, 2019	ExerciseD (derivative)	-1,250	—	n/a (No price was disclosed in the filing)		SEC
STAR OPERATING COMPANIES, INC.Listing on record	Aug 8, 2019	Exercise	1,250	—	n/a (No price was disclosed in the filing)		SEC